Improved stratification of ALS clinical trials using predicted survival.

about

Improved stratification of ALS clinical trials using predicted survival.

Item

http://www.wikidata.org/entity/Q55054303

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Improved stratification of ALS clinical trials using predicted survival.

@en

Improved stratification of ALS clinical trials using predicted survival.

@nl

type

Item

label

Improved stratification of ALS clinical trials using predicted survival.

@en

Improved stratification of ALS clinical trials using predicted survival.

@nl

prefLabel

Improved stratification of ALS clinical trials using predicted survival.

@en

Improved stratification of ALS clinical trials using predicted survival.

@nl

P1476

Improved stratification of ALS clinical trials using predicted survival.

@en

P2093

Albert A Taylor

http://www.w3.org/2001/XMLSchema#string

Amy Bian

http://www.w3.org/2001/XMLSchema#string

Bernard Ravina

http://www.w3.org/2001/XMLSchema#string

Danielle Beaulieu

http://www.w3.org/2001/XMLSchema#string

David L Ennist

http://www.w3.org/2001/XMLSchema#string

James D Berry

http://www.w3.org/2001/XMLSchema#string

Jinsy Andrews

http://www.w3.org/2001/XMLSchema#string

Lisa Meng

http://www.w3.org/2001/XMLSchema#string

Mike Keymer

http://www.w3.org/2001/XMLSchema#string

P2860

Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?

The PRO-ACT database: design, initial analyses, and predictive features

Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression.

Fisher, Bradford Hill, and randomization.

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Randomized phase 2 trial of NP001-a novel immune regulator: Safety and early efficacy in ALS.

Clinical research methodology I: introduction to randomized trials.

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.

Gradient boosting machines, a tutorial.

A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.

P304

474-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACN3.550

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29687024

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

5899911

http://www.w3.org/2001/XMLSchema#string